NABIL MOHAMED AHMED
Medical Practice in Houston, TX
License number
Michigan 4301088637
Issued Date
Jun 27, 2006
Expiration Date
Jan 31, 2007
Category
Medicine
Type
Medical Doctor
Address
Address
Houston, TX 77025
Personal information
See more information about NABIL MOHAMED AHMED at radaris.comName
Address
Phone
3414 Norris Dr, Houston, TX 77025
Houston, TX
Professional information
See more information about NABIL MOHAMED AHMED at trustoria.com
Dr. Nabil M Ahmed, Houston TX - MD (Doctor of Medicine)
Dr. Nabil M Ahmed, Houston TX - MD (Doctor of Medicine)
Specialties:
Pediatric Hematology & Oncology
Address:
6701 Fannin St, Houston 77030
(832) 822-4890 (Phone)
(832) 822-4890 (Phone)
Certifications:
Pediatric Oncology & Pediatric Hematology, 2006, Pediatrics, 2003
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
6701 Fannin St, Houston 77030
St. Luke's Medical Center
6720 Bertner Ave, Houston 77030
St. Luke's Medical Center
6720 Bertner Ave, Houston 77030
Education:
Medical School
University Of Cairo, Faculty Of Medicine
University Of Cairo, Faculty Of Medicine
Nabil M Ahmed, Houston TX
Nabil M Ahmed, Houston TX
Specialties:
Pediatric Hematologist / Oncologist
Address:
6701 Fannin St, Houston, TX 77030
1102 Bates Ave, Houston, TX 77030
1102 Bates Ave, Houston, TX 77030
Education:
Bachelor of Medicine, Bachelor of Surgery
Board certifications:
American Board of Pediatrics Sub-certificate in Pediatric Hematology/Oncology (Pediatrics)
Nabil Ahmed, Houston TX
Nabil Ahmed, Houston TX
Work:
Texas Childrens Cancer Center And Hematology Service Clinica
6701 Fannin St, Houston, TX 77030
6701 Fannin St, Houston, TX 77030
Immunotherapy Of Cancer Using Genetically Engineered Gd2-Specific T Cells
Immunotherapy Of Cancer Using Genetically Engineered Gd2-Specific T Cells
US Patent:
2014000, Jan 2, 2014
Filed:
Sep 8, 2011
Appl. No.:
13/820931
Inventors:
Malcolm Brenner - Houston TX, US
Gianpietro Dotti - Houston TX, US
Nabil Ahmed - Houston TX, US
Claudia Rossig - Heidelberg, DE
Stephen M.G. Gottschalk - Houston TX, US
Zakaria Grada - Houston TX, US
Gianpietro Dotti - Houston TX, US
Nabil Ahmed - Houston TX, US
Claudia Rossig - Heidelberg, DE
Stephen M.G. Gottschalk - Houston TX, US
Zakaria Grada - Houston TX, US
International Classification:
C12N 5/0783, C07K 16/18
US Classification:
4241781, 424 9321, 435375
Abstract:
The present invention concerns immunotherapy for cancers having cells that comprise the ganglioside GD2 antigen. In specific embodiment, T cells having a chimeric receptor that targets GD2 is employed. In particular cases, the chimeric receptor comprises antibody, cytoplasmic signaling domain from the T cell receptor, and/or costimulatory molecule(s).
Chimeric Antigen Receptor For Bispecific Activation And Targeting Of T Lymphocytes
Chimeric Antigen Receptor For Bispecific Activation And Targeting Of T Lymphocytes
US Patent:
2013028, Oct 24, 2013
Filed:
Mar 7, 2013
Appl. No.:
13/788267
Inventors:
Nabil Ahmed - Houston TX, US
Zakaria Grada - Houston TX, US
Meenakshi Hedge - Houston TX, US
Matthew Baker - Bellaire TX, US
Donald R. Shaffer - Houston TX, US
Zakaria Grada - Houston TX, US
Meenakshi Hedge - Houston TX, US
Matthew Baker - Bellaire TX, US
Donald R. Shaffer - Houston TX, US
International Classification:
C12N 15/85, A61K 45/06, A61K 35/14
US Classification:
424 9321, 435325, 4353201, 435455
Abstract:
Embodiments of the invention include methods and compositions related to improved cells encoding a chimeric antigen receptor that is specific for two or more antigens. In certain aspects the receptor encompasses two or more non-identical antigen recognition domains. The antigens are tumor antigens, in particular embodiments.